NaTHNaC Clinical Updates
21 May 2009
Ixiaro® Japanese encephalitis vaccine
A new licensed Japanese encephalitis vaccine is now available in the United Kingdom.
The vaccine, ‘Ixiaro®’ is distributed by Novartis Vaccines and is licensed for use in adults aged 18 years and older. The primary schedule consists of two doses of vaccine administered on days 0 and 28. Currently there is a lack of data regarding the timing of booster doses.
Limited supplies of Green Cross Japanese encephalitis vaccine are available from MASTA and can be used in children aged 12 months and older.
The Summary of Product Characteristics (SmPC) for Ixiaro® is available on the Electronic Medicines Compendium website.
Information on the risk of Japanese encephalitis is specific countries is available on the NaTHNaC Country Information Pages.
Novartis Vaccines can be contacted on 08457 451 500.
LinkNaTHNaC Information Sheet on Japanese encephalitis